Factors Affecting Dengue Vaccine Acceptance of Patients at a Hospital in Yala Province
Article Sidebar
Main Article Content
Abstract
Objective: To study the rate of dengue vaccine acceptance and factors affecting the acceptance among patients receiving care at outpatient department of a hospital in Yala. Methods: This research was a cross sectional descriptive study. The researchers interviewed 400 patients receiving care at outpatient department of a hospital in Yala. Questionnaire for the interview consisted of questions on attitudes towards dengue fever, attitudes towards dengue vaccine and dengue vaccine acceptance. Results: 95.0 percent of the subjects accepted the vaccine. Median willingness to pay for 3 doses of the vaccine was 550 baht (inter-quartile range: 277.5, 1,000.0). Six subjects were not willing to pay for dengue vaccine. Logistic regression analysis revealed that factors significantly affecting dengue vaccine acceptance were vaccination services with free of charge (OR=35.93, 95% CI: 10.82-119.31), severity of dengue fever (OR=7.75, 95% CI: 1.93-31.02, P=0.004) and influence from family members (OR=4.76, 95% CI: 1.26-18.02). Conclusion: Nearly all subjects accepted dengue vaccine. Factors affecting the acceptance of dengue vaccine were availability of free vaccine, perceived severity of dengue fever and influences from family members. Prevention of dengue fever needs an understanding on factors affecting the acceptance of the vaccine. The roles of public health officials are to provide information on the severity of the disease, vaccine support and communication with family members on the issue.
Article Details
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
2. World Health Organization. Dengue and dengue hemorrhagic fever [online]. 2017 [cited Oct 15, 2017]. Available from: /www.who.int/mediacentre/ fact sheet s/fs117/en/index.html.
3. Department of Disease Control, Ministry of Public Health. Dengue fever forecast report, Dengue fever situation [online]. 2018. [cited Feb 21, 2019]. Avai lable from: ddc.moph.go.th/th/site/newsview/view/6 96.
4. Shepard D. Economic and disease burden of dengue in Southeast Asia. Plos Neg Trop Dis 2013;7:e2055.
5. World Health Organization. Globle strategy for dengue prevention and control 2012-2020 [online]. 2012. [cited Nov 1, 2017]. Available from: www.who .int /immunization/sage/meetings/2013/april/5_D engue_SAGE_Apr2013_Global_Strategy.pdf.
6. Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Eng J Med 2015; 373: 1195-206.
7. Pediatric Infection Disease Society of Thailand. Guidelines for guidance in the practice of dengue vaccine: Dengvaxia advice for doctors. [online]. 2017 [cited Dec 29, 2017]. Available from: www.pid st.or.th/A601.html.
8. Nokdee C. Dengue Vaccine: Prevent disease from mosquitoes [online]. 2017 [cited Oct 30, 2017]. Ava ilable from: www.thaihealth.or.th.
9. Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Cunha R, Deseda C, et al. Efficacy of a tetrava lent dengue vaccine in children in Latin America. N Eng J Med 2015; 372: 113-23.
10. World Health Organization. Questions and answers on dengue vaccines: Phase III study of CYD-TDV in Latin America [online]. 2014. [cited Oct 1, 2017]. Available from: www.who.int/immunization/research /development/QA_Dengue_vaccine_LA_phIIIstudy_final.pdf.
11. Harapan H, Anwar S, Setiawan AM, Sasmono RT. Dengue vaccine acceptance and associated factors in Indonesia: A community-based cross-sectional survey in Aceh. Vaccine. 2016; 34: 3670–5.
12. Panji FH, Marcia C. Public acceptance and willing ness to pay for a future dengue Vaccine. Plos Neg Trop Dis 2013;7:e2427.
13. Becker MH. The health belief model and personal health behavior. Health Educ Monogr 1974;2:324–508.
14. Sooksripeng B. Health belief model [online]. 2013 [cited Oct 10, 2017]. Available from: www.gotokno w.org/posts/115420.
15. World Health Organization. What influences vaccine acceptance: A model of determinants of vaccine hesitancy [online]. 2013. [cited Oct 1, 2017 ]. Available from: www.who.int/ immunization/ sage /meetings/2013/april/1_Model_analyze_driversofvaccineConfidence_22_March.pdf.
16. Barbacariu CL. Parents’ refusal to vaccinate their children: An increasing social phenomenon which
threatens public health. Procedia Soc Behav Sci 2014;149:84–91.
17. Harmsen IA, Mollema L, Ruiter RA, Paulussen TG, de Melker HE, Kok G. Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health 2013; 13: 1183.
18. Fredrickson DD, Davis TC, Arnould CL, Kennen EM, Hurniston SG, Cross JT, et al. Childhood immu nization refusal: provider and parent perceptions. Fam Med 2004; 36: 431–9.
19. Yaqub O, Castle-Clarke S, Sevdalis N, Chataway J. Attitudes to vaccination: a critical review. Soc Sci
Med 2014; 112: 1–11.
20. Jung-Seok L, Vittal M, Lim JK, Mabel C, Chukiat S, Anh DD, Lee KS, et al. A multi-country study of the
household willingness-to-pay for dengue vaccines: Household surveys in Vietnam, Thailand, and Colombia. PloS Neg Trop Dis 2015;9:e0003810.
